(CRA) Celera Corporation Posts Break-Even Earnings
Celera Corp. (CRA) reported break-even earnings in the third-quarter, compared to the Zacks Consensus Estimate of a loss of 6 cents. The company earned a cent in the year-ago quarter. Net revenues for...
View Article(CPHD) Cepheid Narrows Loss
Cepheid’s (CPHD) third quarter net loss per share of 6 cents was much better than the Zacks Consensus Estimate of 12 cents as well as a loss of 12 cents reported in the third quarter of 2008. Although...
View Article(CPHD) Cepheid’s H1N1 Test Earns Emergency Use Authorization
Recently, Cepheid (CPHD) received an Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its Xpert Flu A Panel test, which is for identifying the H1N1 influenza virus...
View Article(CPHD) Cepheid Targets Infectious Diseases
Cepheid (CPHD) announced the appointment of Robert Kwiatkowski as the Vice President of Infectious Disease Research and Development. He would be reporting to David Persing, the company’s Chief Medical...
View Article(CNW) Company News for July 7, 2011 – Corporate Summary
• Share prices of disk-drive components suppliers Hutchinson Technology Inc. (NASDAQ:HTCH) shot up by 21.15% after the company said it is optimistic about posting higher-than-expected third quarter...
View Article(AAPL) 2011 Second Quarter Earnings Preview – Detailed
Earnings Preview 7/15/11 Second quarter earnings season is now under way, but things really start to move into high gear next week. There will be 348 firms reporting, and 108 of those are in the...
View Article(AAPL) A Busy Week Ahead – Earnings Preview
Earnings Preview 10/14/11 While the earnings season kicked off this past week, only 38 firms reported. The game really gets under way next week, when we will get reports from 336 firms, including 99...
View Article(CPHD) Cepheid’s Preliminary 3Q Disappoints
After reporting a disappointing second quarter 2012, Cepheid’s (CPHD) preliminary results for the third quarter of 2012 were also below the consensus estimate. The company is likely to report revenues...
View Article(CUTR) Biolase Gets U.S. Food & Drug Administration Nod for EPIC 10S
Recently, a pioneer in manufacturing and distributing dental lasers, BIOLASE, Inc. (BIOL) obtained regulatory clearance from the U.S. Food & Drug Administration (FDA) for its EPIC 10S soft tissue...
View Article(CVD) Covance Augments Singapore Facility
Covance Inc. (CVD) recently announced that it had completed the expansion of its central laboratory facility in Singapore. Following the expansion of the laboratory by 50%, the company will be able to...
View Article(VOLC) Volcano Corporation Stays Neutral
Recently, we have reaffirmed our Neutral recommendation on Volcano Corporation (VOLC). Although we are concerned about the company’s disappointing fourth quarter 2012 and conservative outlook for 2013,...
View Article(ABMD) Abiomed Releases Encouraging Preliminary Fourth Quarter Data
Leading cardiac assist devices maker, Abiomed Inc. (ABMD), provided encouraging preliminary data for its fourth-quarter 2013 results. The company will report full results on May 2, 2013. Revenues...
View Article(AMED) Amedisys Posts Huge Earnings Miss – Guides Lower
Home healthcare provider Amedisys (AMED) reported net income of $3.9 million or 9 cents per share in the first quarter of 2013, a considerable slide from net income of $8.6 million or earnings of 18...
View Article
